Neuroscience Trials Australia
Website: https://neurosciencetrialsaustralia.com/
Member Contact: Michael W. Spiegel
Position: General Manager, Corporate Services
Industry: R&D Services
Company Profile:
Neuroscience Trials Australia (NTA) is an Australian-based, niche, not-for-profit contract research organization (CRO) specializing in neuroscience clinical research. We provide a full-service solution across all Phase I-IV trials in Australia.
With an average of 14 plus years plus industry experience, our staff routinely work with pharmaceutical, biotechnology, cell therapy and device companies to undertake their clinical trials according to global regulatory standards, such that the data we collect is acceptable to regulatory authorities such as the TGA, FDA and EMA.
As a wholly owned subsidiary of The Florey, NTA has strategic alliances with many therapeutic disease groups and we can provide access to key opinion leaders, experienced sites and clinical trial expertise through a range of tailored services. Across all our projects we interact with up to 200 CNS-focused sites alone. Any profits that NTA makes is re-directed back into neuroscience academic research at The Florey.
Our areas of expertise include epilepsy, stroke and stroke-related conditions, multiple sclerosis, Alzheimer’s disease/cognitive diseases, mental health, ALS/MND, Parkinson’s disease, spinal cord injuries, Huntington’s disease, neurosurgery, pain, neuromuscular disease and migraine, rare and pediatric disease, ophthalmology as well as first-in-human Phase I studies. We are increasingly working on a number of oncology trials to support our client’s portfolios.
